Posts Tagged: "CBM"

The hearing focused on the effect the Innovation Act would have on the problem of abusive litigation practices and on the patent system as a whole. Three central themes emerged from the hearing: 1) there is an urgent need to fully fund the PTO; 2) significant skepticism remains about expansion of the Covered Business Method (“CBM”) program; and 3) some of the more technical aspects of the Innovation Act would help rid the patent system of expensive and wasteful lawsuits. Divergence of opinion remained among the Members, however, about whether Congress should address fee shifting at this time or wait for the Supreme Court to hear the two fee shifting cases before it, although the witnesses agreed that legislation on fee shifting would be helpful, and Congress should proceed with legislation on this front.

“You’re going to get a claim construction early from the PTAB. In fact, one of the interesting results with the respect to a review of the decisions to initiate inter parted review or covered business method challenges is that the PTAB lays out for you its claim construction findings and its reasons. This may have a tremendous influence on the concurrent litigation and its claim construction. Obviously, the patent owner’s going to say certain things with respect to how the claims should be construed in its patent owner response, but nevertheless such statements may result in a clear disavowel of claim scope. Such admissions will have an impact on the concurrent litigation. Conceptually there are many strategic and tactical issues that are of general applicability to both the litigation and administrative trial.”